Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Oct 31, 2025 | (Q1)Jul 31, 2025 | (FY)Apr 30, 2025 | (Q4)Apr 30, 2025 | (Q3)Jan 31, 2025 | (Q2)Oct 31, 2024 | (Q1)Jul 31, 2024 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -29.82%-429.93K | -22.21%-582.08K | 11.78%-1.84M | 25.93%-555.52K | 1.26%-472.58K | 19.84%-331.17K | -12.00%-476.28K | -5.81%-2.08M | -80.61%-749.97K | -25.93%-478.6K |
| Net income from continuing operations | -94.41%-874.75K | -96.88%-2.46M | -49.89%-4.69M | -115.74%-2.55M | 2.56%-435.37K | 51.12%-449.94K | -116.66%-1.25M | -46.23%-3.13M | -247.05%-1.18M | 34.62%-446.79K |
| Operating gains losses | ---- | ---- | --21.68K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 3.21%44.78K | -3.56%41.62K | 9.97%168.52K | -5.68%38.6K | 14.85%43.38K | 15.80%43.38K | 16.41%43.15K | 21.34%153.24K | -60.55%40.92K | 396.97%37.78K |
| Remuneration paid in stock | --393.44K | ---- | 45.04%1.26M | 262.74%1.26M | --0 | --0 | --0 | 1,082.42%868.47K | 353.74%347.25K | --0 |
| Other non cashItems | 2,038.21%76.1K | 153.04%1.86M | 6,326.74%1.44M | --701.65K | --2.41K | -40.47%3.56K | 9,411.48%734.67K | -38.81%22.44K | ---- | ---- |
| Change In working capital | -196.75%-69.5K | -707.60%-18.07K | -2,402.28%-41.35K | -232.97%-27.94K | -19.28%-83K | 705.84%71.83K | -105.40%-2.24K | 102.77%1.8K | 126.83%21.01K | -181.47%-69.59K |
| -Change in receivables | -560.83%-74.84K | 226.23%38.67K | -1,537.48%-23.32K | -329.67%-32.53K | 5.80%-18.88K | 1,402.41%16.24K | -57.91%11.85K | 150.61%1.62K | 75.65%-7.57K | -127.74%-20.05K |
| -Change in inventory | ---13K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Change in prepaid assets | 96.21%31.76K | 118.49%2.64K | -1,980.38%-213.65K | -9,602.72%-217.34K | -68.24%1.77K | 292.77%16.19K | -465.79%-14.27K | 125.06%11.36K | 83.31%-2.24K | 1,029.55%5.58K |
| -Change in payables and accrued expense | -134.05%-13.42K | -33,641.81%-59.37K | 1,848.44%195.62K | 620.00%221.93K | -19.54%-65.89K | 961.58%39.41K | -98.12%177 | 30.98%-11.19K | 191.19%30.82K | -535.10%-55.12K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -29.82%-429.93K | -22.21%-582.08K | 11.78%-1.84M | 25.93%-555.52K | 1.26%-472.58K | 19.84%-331.17K | -12.00%-476.28K | -5.81%-2.08M | -80.61%-749.97K | -25.93%-478.6K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 43.34%-17.54K | 0 | 0 | 0 | 39.82%-17.54K | -8.06%-30.96K | -1.81K | 0 |
| Net PPE purchase and sale | --0 | --0 | 39.82%-17.54K | --0 | --0 | --0 | 39.82%-17.54K | -1.75%-29.15K | --0 | --0 |
| Net investment purchase and sale | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---1.81K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 43.34%-17.54K | --0 | --0 | --0 | 39.82%-17.54K | -8.06%-30.96K | ---1.81K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -2.53%-39.5K | 881.34%298.34K | 59.26%-58.47K | 202.46%56.75K | -20.86%-38.52K | -9.06%-38.52K | -10.21%-38.18K | -1,418.94%-143.53K | 1.30%-55.39K | -206.24%-31.87K |
| Net issuance payments of debt | -2.53%-39.5K | -2.56%-39.16K | -7.10%-153.72K | 30.50%-38.5K | -20.86%-38.52K | -9.06%-38.52K | -10.21%-38.18K | -15.64%-143.53K | 55.37%-55.39K | ---31.87K |
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | --337.5K | --95.25K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -2.53%-39.5K | 881.34%298.34K | 59.26%-58.47K | 202.46%56.75K | -20.86%-38.52K | -9.06%-38.52K | -10.21%-38.18K | -1,418.94%-143.53K | 1.30%-55.39K | -206.24%-31.87K |
| Net cash flow | ||||||||||
| Beginning cash position | -45.16%2.02M | -45.35%2.3M | -34.86%4.21M | -44.21%2.8M | -40.11%3.31M | -38.42%3.68M | -34.86%4.21M | -23.47%6.47M | -27.65%5.02M | -24.12%5.53M |
| Current changes in cash | -26.98%-469.43K | 46.67%-283.74K | 15.24%-1.91M | 38.21%-498.77K | -0.12%-511.1K | 17.57%-369.69K | -8.79%-532.01K | -13.65%-2.26M | -71.25%-807.17K | -45.82%-510.48K |
| End cash Position | -53.21%1.55M | -45.16%2.02M | -45.35%2.3M | -45.35%2.3M | -44.21%2.8M | -40.11%3.31M | -38.42%3.68M | -34.86%4.21M | -34.86%4.21M | -27.65%5.02M |
| Free cash from | -29.82%-429.93K | -17.87%-582.08K | 11.84%-1.86M | 25.01%-562.39K | 1.26%-472.58K | 19.84%-331.17K | -8.68%-493.82K | -5.75%-2.11M | -80.61%-749.97K | -25.93%-478.6K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.